CD8A and cancer: In PLWH with cancer (any):• Frequency of clinical and biological AEs• Overall response rate, progression free survival rate• Immuno-virological evolution of HIV-infection (CD4 and CD8 T-cell counts, HIV-RNA load, residual plasma HIV-RNA, HIV-specific T-cell responses, and inflammation/activation/exhaustion markers)